Journal article
EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review
- Abstract:
- Since the publication of the Falsified Medicines Directive in 2011 and the subsequent delegated regulation in February 2016, there has been much discussion surrounding the level of Falsified Medicines Directive compliance required by secondary care institutions. Due to the heterogeneous nature of the secondary care drug distribution cycle, the Falsified Medicines Directive allows certain dispensations for ‘healthcare institutions’, this manuscript reviews the Falsified Medicines Directive and delegated regulation in an effort to understand and explain these dispensations and the true impact of the Falsified Medicines Directive on secondary care in an effort to address common misconceptions amongst stakeholders.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 148.5KB, Terms of use)
-
- Publisher copy:
- 10.1177/1741134316643358
Authors
- Publisher:
- SAGE Publications
- Journal:
- Journal of Generic Medicines More from this journal
- Volume:
- 12
- Issue:
- 3-4
- Pages:
- 95-101
- Publication date:
- 2016-06-01
- Acceptance date:
- 2016-04-21
- DOI:
- EISSN:
-
1741-7090
- ISSN:
-
1741-1343
- Keywords:
- Pubs id:
-
pubs:624275
- UUID:
-
uuid:1e7105ce-b1b5-49a0-853e-e49b638e215d
- Local pid:
-
pubs:624275
- Source identifiers:
-
624275
- Deposit date:
-
2016-05-27
- ARK identifier:
Terms of use
- Copyright holder:
- Naughton et al
- Copyright date:
- 2016
- Notes:
- © The Author(s) 2016. This is the accepted manuscript version of the article. The final version is available online from SAGE at: [10.1177/1741134316643358]
If you are the owner of this record, you can report an update to it here: Report update to this record